# AREG

## Overview
Amphiregulin (AREG) is a gene that encodes a protein belonging to the epidermal growth factor (EGF) family, known as amphiregulin. This protein functions as a ligand for the epidermal growth factor receptor (EGFR), playing a pivotal role in various physiological processes, including cell proliferation, differentiation, and tissue development. Amphiregulin is characterized by its structure, which includes a signal peptide, an EGF-like domain, and a transmembrane domain, facilitating its interaction with cellular components and signaling pathways. The protein is involved in critical biological functions such as mammary gland development, keratinocyte proliferation, and tissue remodeling. It is also implicated in pathological conditions, including cancer and inflammatory diseases, where its expression and interaction with EGFR influence disease progression and treatment responses (Busser2011The; Sisto2017Exocrine; Stoll2015The).

## Structure
Amphiregulin (AREG) is a protein that belongs to the epidermal growth factor (EGF) family. Its primary structure is characterized by a polypeptide chain that includes a signal peptide, an EGF-like domain, and a transmembrane domain. The secondary structure of AREG comprises alpha helices and beta sheets, which contribute to its functional conformation. 

Post-translational modifications of AREG often involve glycosylation, which can affect its stability and activity. These modifications are crucial for the protein's proper function and interaction with other cellular components. AREG is known to exist in multiple splice variant isoforms, which may result in differences in its biological activity and regulatory mechanisms. 

The presence of an EGF-like domain is significant as it plays a role in binding to the EGF receptor, facilitating signal transduction pathways that are essential for cell proliferation and differentiation. The transmembrane domain anchors the protein within the cell membrane, allowing it to interact with extracellular signals and intracellular pathways effectively. 

Overall, the structural features of AREG, including its domains and post-translational modifications, are integral to its role in cellular processes.

## Function
Amphiregulin (AREG) is a ligand for the epidermal growth factor receptor (EGFR) and plays a significant role in various physiological processes in healthy human cells. It is involved in the development of mammary glands, blastocyst implantation, bone formation, axonal outgrowth, and keratinocyte proliferation. AREG is primarily expressed in the reproductive and urinary systems, pancreas, circulatory system, and respiratory and gastrointestinal tracts. It is crucial for mammary gland development during puberty and gestation, where it induces proliferation upon estrogen and progesterone stimulation and activates intracellular pathways like ERK and AKT to regulate cell proliferation (Busser2011The).

AREG is also important in keratinocyte proliferation and differentiation, essential for maintaining epidermal homeostasis. It functions as the predominant autocrine growth factor for cultured keratinocytes and is significantly upregulated in hyperproliferative skin conditions such as psoriasis and wound healing. AREG activates EGFR, regulating keratinocyte functions, including migration, proliferation, differentiation, survival, and immune response activation (Stoll2015The).

In addition, AREG contributes to the branching and tubulogenesis processes in tissues such as the prostate, kidneys, and lungs, and is involved in oocyte maturation and spermatogenesis (Busser2011The).

## Clinical Significance
Amphiregulin (AREG) is implicated in various cancers and inflammatory diseases due to alterations in its expression levels and interactions. In astrocytomas, a type of brain tumor, AREG expression and methylation levels vary with tumor grade. Higher methylation and lower protein expression of AREG are associated with better survival outcomes, suggesting its potential as a prognostic biomarker (Steponaitis2019Significance). In colorectal cancer, AREG expression is linked to treatment responses, with high expression correlating with improved outcomes in patients treated with anti-EGFR therapy (Lee2016Association). AREG is also overexpressed in various other cancers, including breast, lung, and colorectal cancers, where it contributes to tumor progression, metastasis, and treatment resistance (Busser2011The).

AREG's role extends to inflammatory diseases, where it is involved in tissue remodeling and inflammation. It is implicated in conditions such as psoriasis and rheumatoid arthritis, contributing to the inflammatory response through the EGF/EGFR signaling pathway (Sisto2017Exocrine). These findings highlight AREG's significance in both oncogenic processes and inflammatory diseases, making it a potential target for therapeutic interventions.

## Interactions
Amphiregulin (AREG) interacts with several proteins, primarily involving the epidermal growth factor receptor (EGFR). AREG binds to EGFR, leading to the formation of EGFR homo- and hetero-dimers, which induces autophosphorylation through EGFR tyrosine kinase activity. This interaction affects signaling pathways, including the Ras/Raf/MEK/ERK and PI3K/Akt pathways, promoting cell proliferation and motility (Sisto2017Exocrine).

AREG is synthesized as a transmembrane glycoprotein and undergoes ectodomain cleavage to release soluble forms. This shedding process is mediated by ADAM17, a key enzyme that regulates the release of AREG from the cell surface. Annexins, particularly ANXA2, ANXA8, and ANXA9, interact with proAREG and ADAM17, forming a complex that influences the shedding process. These interactions are crucial for EGFR transactivation, especially in keratinocytes under UVB-induced conditions (Nakayama2012Cell).

The interaction between AREG and annexins is constitutive, and knockdown of annexins alters the interaction with ADAM17, affecting the shedding process. ANXA8 is particularly important for the formation of the proAREG assembly complex, and its knockdown affects cell motility, indicating its role in keratinocyte migration (Nakayama2012Cell).


## References


[1. (Nakayama2012Cell) Hironao Nakayama, Shinji Fukuda, Hirofumi Inoue, Hisayo Nishida-Fukuda, Yuji Shirakata, Koji Hashimoto, and Shigeki Higashiyama. Cell surface annexins regulate adam-mediated ectodomain shedding of proamphiregulin. Molecular Biology of the Cell, 23(10):1964–1975, May 2012. URL: http://dx.doi.org/10.1091/mbc.e11-08-0683, doi:10.1091/mbc.e11-08-0683. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e11-08-0683)

[2. (Stoll2015The) S W Stoll, P E Stuart, W R Swindell, L C Tsoi, B Li, A Gandarillas, S Lambert, A Johnston, R P Nair, and J T Elder. The egf receptor ligand amphiregulin controls cell division via foxm1. Oncogene, 35(16):2075–2086, August 2015. URL: http://dx.doi.org/10.1038/onc.2015.269, doi:10.1038/onc.2015.269. This article has 31 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2015.269)

[3. (Busser2011The) Benoit Busser, Lucie Sancey, Elisabeth Brambilla, Jean-Luc Coll, and Amandine Hurbin. The multiple roles of amphiregulin in human cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1816(2):119–131, December 2011. URL: http://dx.doi.org/10.1016/j.bbcan.2011.05.003, doi:10.1016/j.bbcan.2011.05.003. This article has 67 citations.](https://doi.org/10.1016/j.bbcan.2011.05.003)

[4. (Lee2016Association) Michael S Lee, Elizabeth J McGuffey, Jeffrey S Morris, Ganiraju Manyam, Veerabahdran Baladandayuthapani, Wei Wei, Van K Morris, Michael J Overman, Dipen M Maru, Zhi-Qin Jiang, Stanley R Hamilton, and Scott Kopetz. Association of cpg island methylator phenotype and ereg/areg methylation and expression in colorectal cancer. British Journal of Cancer, 114(12):1352–1361, June 2016. URL: http://dx.doi.org/10.1038/bjc.2016.87, doi:10.1038/bjc.2016.87. This article has 72 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/bjc.2016.87)

[5. (Sisto2017Exocrine) Margherita Sisto, Loredana Lorusso, Giuseppe Ingravallo, and Sabrina Lisi. Exocrine gland morphogenesis: insights into the role of amphiregulin from development to disease. Archivum Immunologiae et Therapiae Experimentalis, 65(6):477–499, June 2017. URL: http://dx.doi.org/10.1007/s00005-017-0478-2, doi:10.1007/s00005-017-0478-2. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00005-017-0478-2)

[6. (Steponaitis2019Significance) Giedrius Steponaitis, Arunas Kazlauskas, Daina Skiriute, Paulina Vaitkiene, Kestutis Skauminas, and Arimantas Tamasauskas. Significance of amphiregulin (areg) for the outcome of low and high grade astrocytoma patients. Journal of Cancer, 10(6):1479–1488, 2019. URL: http://dx.doi.org/10.7150/jca.29282, doi:10.7150/jca.29282. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/jca.29282)